Vonaprument: Only Geographic Atrophy Program to Show Significant Vision Preservation Oct 03, 2025 Tanruprubart: First-in-Kind Targeted Therapy for Guillain-Barré Syndrome Sep 04, 2025 ANX1502 First in Human SAD / MAD Data Overview Dec 21, 2023